Prevalence Distribution and Risk Factors for Schistosoma hematobium Infection among School Children in Blantyre, Malawi

Schistosoma hematobium infection is a parasitic infection endemic in Malawi. Schistosomiasis usually shows a focal distribution of infection and it is important to identify communities at high risk of infection and assess effectiveness of control programs. We conducted a survey in one district in Malawi to determine prevalence and factors associated with S. hematobium infection among primary school pupils. Using a questionnaire, information on history of passing bloody urine and known risk factors associated with infection was collected. Urine samples were collected and examined for S. hematobium eggs. One thousand one hundred and fifty (1,150) pupils were interviewed, and out of 1,139 pupils who submitted urine samples, 10.4% were infected. Our data showed that male gender, child's knowledge of an existing open water source (includes river, dam, springs, lake, etc.) in the area, history of urinary schistosomiasis in the past month, distance of less than 1 km from school to nearest open water source and age 8–10 years compared to those 14 years and older were independently associated with infection. These findings suggest that children attending schools in close proximity to open water sources are at increased risk of infection

NEOTROPICAL XENARTHRANS: a data set of occurrence of xenarthran species in the Neotropics

Xenarthrans – anteaters, sloths, and armadillos – have essential functions for ecosystem maintenance, such as insect control and nutrient cycling, playing key roles as ecosystem engineers. Because of habitat loss and fragmentation, hunting pressure, and conflicts with 24 domestic dogs, these species have been threatened locally, regionally, or even across their full distribution ranges. The Neotropics harbor 21 species of armadillos, ten anteaters, and six sloths. Our dataset includes the families Chlamyphoridae (13), Dasypodidae (7), Myrmecophagidae (3), Bradypodidae (4), and Megalonychidae (2). We have no occurrence data on Dasypus pilosus (Dasypodidae). Regarding Cyclopedidae, until recently, only one species was recognized, but new genetic studies have revealed that the group is represented by seven species. In this data-paper, we compiled a total of 42,528 records of 31 species, represented by occurrence and quantitative data, totaling 24,847 unique georeferenced records. The geographic range is from the south of the USA, Mexico, and Caribbean countries at the northern portion of the Neotropics, to its austral distribution in Argentina, Paraguay, Chile, and Uruguay. Regarding anteaters, Myrmecophaga tridactyla has the most records (n=5,941), and Cyclopes sp. has the fewest (n=240). The armadillo species with the most data is Dasypus novemcinctus (n=11,588), and the least recorded for Calyptophractus retusus (n=33). With regards to sloth species, Bradypus variegatus has the most records (n=962), and Bradypus pygmaeus has the fewest (n=12). Our main objective with Neotropical Xenarthrans is to make occurrence and quantitative data available to facilitate more ecological research, particularly if we integrate the xenarthran data with other datasets of Neotropical Series which will become available very soon (i.e. Neotropical Carnivores, Neotropical Invasive Mammals, and Neotropical Hunters and Dogs). Therefore, studies on trophic cascades, hunting pressure, habitat loss, fragmentation effects, species invasion, and climate change effects will be possible with the Neotropical Xenarthrans dataset

International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database - the quality controlled standard tool for routine identification of human and animal pathogenic fungi

Human and animal fungal pathogens are a growing threat worldwide leading to emerging infections and creating new risks for established ones. There is a growing need for a rapid and accurate identification of pathogens to enable early diagnosis and targeted antifungal therapy. Morphological and biochemical identification methods are time-consuming and require trained experts. Alternatively, molecular methods, such as DNA barcoding, a powerful and easy tool for rapid monophasic identification, offer a practical approach for species identification and less demanding in terms of taxonomical expertise. However, its wide-spread use is still limited by a lack of quality-controlled reference databases and the evolving recognition and definition of new fungal species/complexes. An international consortium of medical mycology laboratories was formed aiming to establish a quality controlled ITS database under the umbrella of the ISHAM working group on "DNA barcoding of human and animal pathogenic fungi." A new database, containing 2800 ITS sequences representing 421 fungal species, providing the medical community with a freely accessible tool at http://www.isham.org and http://its.mycologylab.org/ to rapidly and reliably identify most agents of mycoses, was established. The generated sequences included in the new database were used to evaluate the variation and overall utility of the ITS region for the identification of pathogenic fungi at intra-and interspecies level. The average intraspecies variation ranged from 0 to 2.25%. This highlighted selected pathogenic fungal species, such as the dermatophytes and emerging yeast, for which additional molecular methods/genetic markers are required for their reliable identification from clinical and veterinary specimens.This study was supported by an National Health and Medical Research Council of Australia (NH&MRC) grant [#APP1031952] to W Meyer, S Chen, V Robert, and D Ellis; CNPq [350338/2000-0] and FAPERJ [E-26/103.157/2011] grants to RM Zancope-Oliveira; CNPq [308011/2010-4] and FAPESP [2007/08575-1] Fundacao de Amparo Pesquisa do Estado de So Paulo (FAPESP) grants to AL Colombo; PEst-OE/BIA/UI4050/2014 from Fundacao para a Ciencia e Tecnologia (FCT) to C Pais; the Belgian Science Policy Office (Belspo) to BCCM/IHEM; the MEXBOL program of CONACyT-Mexico, [ref. number: 1228961 to ML Taylor and [122481] to C Toriello; the Institut Pasteur and Institut de Veil le Sanitaire to F Dromer and D Garcia-Hermoso; and the grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG) to CM de Almeida Soares and JA Parente Rocha. I Arthur would like to thank G Cherian, A Higgins and the staff of the Molecular Diagnostics Laboratory, Division of Microbiology and Infectious Diseases, Path West, QEII Medial Centre. Dromer would like to thank for the technical help of the sequencing facility and specifically that of I, Diancourt, A-S Delannoy-Vieillard, J-M Thiberge (Genotyping of Pathogens and Public Health, Institut Pasteur). RM Zancope-Oliveira would like to thank the Genomic/DNA Sequencing Platform at Fundacao Oswaldo Cruz-PDTIS/FIOCRUZ [RPT01A], Brazil for the sequencing. B Robbertse and CL Schoch acknowledge support from the Intramural Research Program of the NIH, National Library of Medicine. T Sorrell's work is funded by the NH&MRC of Australia; she is a Sydney Medical School Foundation Fellow.info:eu-repo/semantics/publishedVersio

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

OBJECTIVE: To evaluate whether eculizumab helps patients with anti-acetylcholine receptor-positive (AChR+) refractory generalized myasthenia gravis (gMG) achieve the Myasthenia Gravis Foundation of America (MGFA) post-intervention status of minimal manifestations (MM), we assessed patients' status throughout REGAIN (Safety and Efficacy of Eculizumab in AChR+ Refractory Generalized Myasthenia Gravis) and its open-label extension. METHODS: Patients who completed the REGAIN randomized controlled trial and continued into the open-label extension were included in this tertiary endpoint analysis. Patients were assessed for the MGFA post-intervention status of improved, unchanged, worse, MM, and pharmacologic remission at defined time points during REGAIN and through week 130 of the open-label study. RESULTS: A total of 117 patients completed REGAIN and continued into the open-label study (eculizumab/eculizumab: 56; placebo/eculizumab: 61). At week 26 of REGAIN, more eculizumab-treated patients than placebo-treated patients achieved a status of improved (60.7% vs 41.7%) or MM (25.0% vs 13.3%; common OR: 2.3; 95% CI: 1.1-4.5). After 130 weeks of eculizumab treatment, 88.0% of patients achieved improved status and 57.3% of patients achieved MM status. The safety profile of eculizumab was consistent with its known profile and no new safety signals were detected. CONCLUSION: Eculizumab led to rapid and sustained achievement of MM in patients with AChR+ refractory gMG. These findings support the use of eculizumab in this previously difficult-to-treat patient population. CLINICALTRIALSGOV IDENTIFIER: REGAIN, NCT01997229; REGAIN open-label extension, NCT02301624. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that, after 26 weeks of eculizumab treatment, 25.0% of adults with AChR+ refractory gMG achieved MM, compared with 13.3% who received placebo

Rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART): Study protocol for a randomized controlled trial

Background: Acute respiratory distress syndrome (ARDS) is associated with high in-hospital mortality. Alveolar recruitment followed by ventilation at optimal titrated PEEP may reduce ventilator-induced lung injury and improve oxygenation in patients with ARDS, but the effects on mortality and other clinical outcomes remain unknown. This article reports the rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART). Methods/Design: ART is a pragmatic, multicenter, randomized (concealed), controlled trial, which aims to determine if maximum stepwise alveolar recruitment associated with PEEP titration is able to increase 28-day survival in patients with ARDS compared to conventional treatment (ARDSNet strategy). We will enroll adult patients with ARDS of less than 72 h duration. The intervention group will receive an alveolar recruitment maneuver, with stepwise increases of PEEP achieving 45 cmH(2)O and peak pressure of 60 cmH2O, followed by ventilation with optimal PEEP titrated according to the static compliance of the respiratory system. In the control group, mechanical ventilation will follow a conventional protocol (ARDSNet). In both groups, we will use controlled volume mode with low tidal volumes (4 to 6 mL/kg of predicted body weight) and targeting plateau pressure <= 30 cmH2O. The primary outcome is 28-day survival, and the secondary outcomes are: length of ICU stay; length of hospital stay; pneumothorax requiring chest tube during first 7 days; barotrauma during first 7 days; mechanical ventilation-free days from days 1 to 28; ICU, in-hospital, and 6-month survival. ART is an event-guided trial planned to last until 520 events (deaths within 28 days) are observed. These events allow detection of a hazard ratio of 0.75, with 90% power and two-tailed type I error of 5%. All analysis will follow the intention-to-treat principle. Discussion: If the ART strategy with maximum recruitment and PEEP titration improves 28-day survival, this will represent a notable advance to the care of ARDS patients. Conversely, if the ART strategy is similar or inferior to the current evidence-based strategy (ARDSNet), this should also change current practice as many institutions routinely employ recruitment maneuvers and set PEEP levels according to some titration method.Hospital do Coracao (HCor) as part of the Program 'Hospitais de Excelencia a Servico do SUS (PROADI-SUS)'Brazilian Ministry of Healt

The Users' Perception Of A Health Promotion And Prevention Program Offer: A Self-management Operator Case [a Percepção Dos Usuários Sobre A Oferta De Programas De Promoção Da Saúde E Prevenção De Doenças: O Caso De Uma Operadora De Autogestão]

The coexistence of public and private health care systems in Brazil is old and their arrangements have contributed to the construction of a fragmented system. In seeking to establish policies in agreement with the Brazilian Unifed Health System, the National Agency of Supplemental Health insurance has encouraged the development of programs for health promotion and disease prevention on the private sector. These actions are a heterogeneous set of strategies to consolidate policies aiming at the population's health. This is a qualitative study that analyzes these preventive programs in a private health insurance agency, to understand whether they produce bio-political devices. Speeches were collected from users of the programs through a semi-structured script using the technique of content analysis. The results show that some restructuring processes of care production are ongoing, and relational aspects have been targeted in these programs. These actions are configured in devices leading biopolitical forms of life. It is important to have balance between these powers and the production practices of freedom, noting that there is no arbitrary and authoritarian biopolitical interventions in the production of health actions.212449469Aciole, G.G., (2006) A Saúde No Brasil: Cartografias Do Público E Do Privado, , São Paulo: HucitecAgamben, G., (2004) Homo Sacer: O Poder Soberano E a Vida Nua, , Belo Horizonte: UFMGAl-Buque, R.C., A situação atual do mercado de saúde suplementar no Brasil e apontamentos para o futuro (2008) Ciência Saúde Coletiva, 13 (5), pp. 1421-1430. , Rio de JaneiroAyres, J.R.C.M., Cuidado e reconstrução das práticas de saúde (2004) Interface, Comunicação, Saúde E Educação, 8 (14), pp. 73-92Baremblitt, G., (1992) Compêndio De Análise Institucional E Outras Correntes, , Belo Horizonte: Instituto Félix GuattariBardin, L., (2009) Análise De Conteúdo, p. 70. , Lisboa: EdiçõesLei No 9656, De 3 De Junho De 1998. Dispõe Sobre Os Planos E Seguros Privados De Assistência À Saúde, , http://www.planalto.gov.br, BRASIL, Diário Oficial [da] República Federativa do Brasil, Brasília, 4 de junho de 1998, Acesso em: 19 jun 2009(2007) Agência Nacional De Saúde Suplementar, , BRASIL, Promoção da saúde e prevenção de riscos e doenças na saúde suplementar: manual técnico. 2. ed. Rio de Janeiro: ANS(2008) Agência Nacional De Saúde Suplementar, , BRASIL, Panorama das ações de promoção da saúde e prevenção de riscos e doenças na saúde suplementar. Rio de Janeiro: ANSBub, M.B.C., A noção de cuidado de si mesmo e o conceito de autocuidado na enfermagem (2006) Texto Contexto Enfermagem, 15, pp. 152-157Campos, C.J.G., Método de análise de conteúdo: Ferramenta para análise de dados qualitativos no campo da saúde (2004) Revista Brasileira De Enfermagem, 57 (5), pp. 611-614. , Brasíliade Carta, O.W.A., (1986) Primeira Conferência Internacional Sobre Promoção Da Saúde, , OttawaCarvalho, S.R., (2007) Saúde Coletiva E Promoção Da Saúde: Sujeito E Mudança, , 2. ed. São Paulo: HucitecCarval, H.S.R., Gastaldo, D., Promoção à saúde e empoderamento: Uma reflexão a partir das perspectivas crítico-social pós-estruturalista (2008) Ciência Saúde Coletiva, 13 (2), pp. 2029-2040. , Rio de JaneiroCaval r., C.J.G., O Cuidado De Si: Por Uma Hermenêutica Mais Próxima Do Sujeito, , http://fap.com.br/fapciencia/002/edicao_2008/007.pdf, Acesso em: 8 out. 2009Cechin, J., (2008) A História E Os Desafios Da Saúde Suplementar: 10 Anos De Regulação, , São Paulo: SaraivaCeccim, R.B., Carval, H.Y.M., Ensino da saúde como projeto da integralidade: 467 a educação dos profissionais de saúde no SUS (2005) Ensinar Saúde: A Integralidade E O SUS Nos Cursos De Graduação Na Área De Saúde, pp. 69-92. , In: PINHEIRO, R.CECCIM, R.B.MATTOS, R.A. Org., Rio de Janeiro: CepescCosta, V.T., Luna, R.V.L., Luna, R.F.W.D., Autonomia versus cronicidade: Uma questão ética no processo de cuidar em enfermagem Revista De Enfermagem Da UERJ, 15 (1), pp. 53-58. , jan./mar. 2007Fleu, R.-T.P., Autonomia como categoria central no conceito de promoção da saúde (2008) Rev. Ciência Saúde Coletiva, 13 (2), pp. 2115-2122. , Rio de JaneiroFoucault, M., (2006) A Hermenêutica Do Sujeito, , São Paulo: Martins FontesFoucault, M., (2007) A História Da Sexualidade III: O Cuidado De Si, , Rio de Janeiro: GraalFoucault, M., (1999) Em Defesa Da Sociedade, , São Paulo: Martins FontesFoucault, M., (1984) Microfísica Do Poder, , 4. ed Rio de Janeiro: GraalFoucault, M., (2008) Nascimento Da Biopolítica: Curso Dado No Collège De France (1978-1979), , São Paulo: Martins FontesFoucault, M., (2009) Vigiar E Punir: Nascimento Da Prisão, p. 36. , ed. Petrópolis: VozesFran, C.T.B., Merhy, E.E., Atenção domiciliar na saúde suplementar: Dispositivo da reestruturação produtiva (2008) Revista Ciência E Saúde Coletiva, 13 (5), pp. 1511-1520. , Rio de JaneiroFran, C.O.T.B., (2003) Processo De Trabalho E Transição Tecnológica Na Saúde: Um Olhar a Partir Do Cartão Nacional De Saúde2003, , Tese (Doutorado em Saúde Coletiva). Campinas: Universidade Estadual de Campinas, CampinasFreire, P., (1996) Pedagogia Da Autonomia: Saberes Necessários À Prática Educativa, p. 39. , ed. São Paulo: Paz e TerraGerschaman, S., Políticas comparadas de saúde suplementar no contexto de sistemas públicos de saúde: União Europeia e Brasil (2008) Ciência Saúde Coletiva, 13 (5), pp. 1441-1451Heimann, L.S., Iban, H.L.C., Barboza, R., (2005) O Público E O Privado Na Saúde, , São Paulo: HucitecJapiassu, H., (1976) Interdisciplinaridade E Patologia Do Saber, , Rio de Janeiro: ImagoLima, R.C.D., SUS e as teias de diálogos: (im)pertinentes para transformar a formação dos trabalhadores de saúde com vistas à humanização das práticas (2009) Revista Interface - Comunicação, Saúde E Educação, 13 (1), pp. 789-791Lo Bato, L.V.C., Giovanella, L., Sistemas de saúde: Origens, componentes e dinâmica (2008) Políticas E Sistema De Saúde No Brasil, pp. 107-140. , In: GIOVANELLA, L. et al. (Org.), Rio de Janeiro: FiocruzLuz, M.T., (2007) É a Promoção Da Saúde Um Novo Paradigma, pp. 217-225. , In: Ordem social, instituições e políticas de saúde no Brasil. Rio de Janeiro: CepescMerhy, E.E., (2009) O Desafio Da Tutela E Da Autonomia: Uma Tensão Permanente Do Ato De Cuidar, , http://www.uff.br/saudecoletiva/professores/merhy/indexados.11.pdf, Acesso em: 8 out. 2009Merhy, E.E., Fran, C.T.B., (2006) Reestruturação Produtiva Em Saúde, pp. 225-230. , In: FIOCRUZ. Dicionário da Educação profissional em Saúde. Rio de Janeiro: FiocruzMina, Y.M.C.S., Hartz, Z.M.A., Buss, P.M., Qualidade de vida e saúde: Um debate necessário (2000) Ciência Saúde Coletiva, 5 (1), pp. 7-18. , Rio de JaneiroMina, Y.M.C.S., (2006) O Desafio Do Conhecimento: Pesquisa Qualitativa Em Saúde, p. 6. , ed. São Paulo: HucitecPelbart, P.P., (2003) Vida Capital: Ensaios De Biopolítica, , São Paulo: IluminurasPogrebins, C.T., Foucault, para além do poder disciplinar e do biopoder (2004) Lua Nova, Revista De Cultura E Política, 63, pp. 179-201. , São PauloSantos, F.P., Malta, D.C., Merhy, E.E., A regulação na saúde suplementar: Uma análise dos principais resultados alcançados (2008) Ciência Saúde Coletiva, 13 (5), pp. 1463-1475. , Rio de JaneiroSilveira, L.S., (2004) Prevenção De Doenças E Promoção Da Saúde: Diferenciais Estratégicos Na Conjuntura Do Mercado De Saúde Suplementar. 2004, p. 113. , f. Dissertação (Mestrado em Saúde Suplementar)- Escola Nacional de Saúde Pública, Rio de Janeir